First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 373-376

  McQuade, David ^a   Hudson, Simon ^b   Dargan, Paul I ^a,c   Wood, David M ^a,c,d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b LGC   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

AM 2201; Cannabis; K2; Recreational drugs; SCRA; Spice; Synthetic cannabinoid receptor agonist

Indexed keywords

CANNABINOID RECEPTOR AGONIST; GLUCOSE; NEUTRAL INSULIN;

ACUTE TOXICITY; ADULT; ARTICLE; CASE REPORT; DROWSINESS; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SCREENING; TONIC CLONIC SEIZURE; URINALYSIS;

CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMERGENCY SERVICE, HOSPITAL; EPILEPSY, TONIC-CLONIC; GREAT BRITAIN; HUMANS; MALE; MASS SPECTROMETRY; SMOKING; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84877103777     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1379-2     Document Type: Article

References (27)

1. Home Office Statistical Bulletin (2012) Drug Misuse Declared: Findings from the 2010/11 British Crime Survey Available from: http://www.homeoffice.gov. uk/publications/science-research-statistics/research-statistics/crime-research/ hosb1211/hosb1211?view=Binary [Last accessed 19th March]
2. Wood DM, Ramsey J, Dargan PI (2008) Detecting novel and emerging recreational drugs on the 'club scene'. Irish Psychiatrist 9:223-228
3. Wood DM, Measham F, Dargan PI (2012) 'Our Favourite Drug': Prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. J Subs Use In press
4. Measham F, Wood DM, Dargan PI, Moore K (2011) The rise in legal highs: prevalence and patterns in the use of illegal drugs and first and second generation 'legal highs' in south London gay dance clubs. J Subs Use 16:263-272
5. Dick D, Torrance C (2010) Drugs survey. MixMag 225:44-53
6. EMCDDA Annual Report 2011: Annual report on the state of the drugs problem in Europe. Available from: http://www.emcdda.europa.eu/attachements.cfm/ att-143743-EN-EMCDDA-AR2011-EN.pdf [Last accessed 19th March 2012]
7. Wells DL, Ott CA (2011) The "new" marijuana. Ann Pharmacothe 45:414-417
8. European Monitoring Centre for Drugs and Drug Addiction. Understanding the "Spice" Phenomenon (2009) Available from: http://www.emcdda. europa.eu/attachements.cfm/att-80086-EN- Spice%20Thematic%20paper%20%E2%80%94%20final%20version.pdf [Last accessed 19th March 2012]
9. Dargan PI, Hudson S, Ramsey J, Wood DM (2011) The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. Int J Drug Policy 22:274-277
10. Wood DM, Dargan PI (2012) Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances. Ther Drug Monitor In press
11. Rosenbaum C, Carreiro S, Babu K (2012) Here today, gone tomorrow.and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (Bath Salts), kratom, salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8:15-32
12. Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH (2011) Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila) 49:760-764
13. Simmons J, Cookman L, Kang C, Skinner C (2011) Three cases of "spice" exposure. Clin Toxicol (Phila) 49:431-433
14. Schneir A, Baumbacher T (2012) Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol 8:62-64
15. Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771-784
16. Deluca P, Shifano F, Davey Z, Corazza O, di Furia L, Farre M et al (2009) Spice report by the psychonaut web mapping research project. Institute of Psychiatry, King' s College London, London
17. Vardakou I, Pistos C, Spiliopoulou C (2010) Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 197:157-162
18. Simmons JR, Skinner CG, Williams J, Kang CS, Schwartz MD, Wills BK (2011) Intoxication from smoking "spice". Ann Emerg Med 57:187-188
19. Banerji S, Deutsch CM, Bronstein AC (2010) Spice ain't so nice. Clin Toxicol 48:632
20. Bebarta VS, Varney S, Sessions D et al (2010) Spice: a new "legal" herbal mixture abused by young active duty military personnel. Clin Toxicol 48:632
21. Simmons J, Cookman L, Kang C, Skinner C (2011) Three caes of "spice" exposure. Clin Toxicol 49:431-433
22. Schneir AB, Cullen J, Ly BT (2011) "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med 40:296-299
23. Vearrier D, Osterhoudt KC (2010) A teenager with agitation. Pediatr Emerg Care 26:462-464
24. Canning JC, Ruha A-M, Pierce R, Torrey M, Reinhart SJ (2010) Severe gi distress after smoking JWH-018. Clin Toxicol 48:618
25. Muller H, Sperling W, Kohrmann M et al (2010) The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res 118:309-310
26. Sobolevsky T, Prasolov I, Rodchenkov G (2010) Detection of JWH-018 metabolites in smoking mixture post administration urine. Forensic Sci Int 200:141-147
27. Möller I, Wintermeyer A, Bender K, Jübner M, Thomas A, Krug O, Schänzer W, Thevis M (2011) Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Anal 3:609-620